Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands
Abstract Background The Open Targets Platform integrates different data sources in order to facilitate identification of potential therapeutic drug targets to treat human diseases. It currently provides evidence for nearly 2.6 million potential target-disease pairs. G-protein coupled receptors are a...
Main Authors: | Johannes M Freudenberg, Ian Dunham, Philippe Sanseau, Deepak K Rajpal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-018-2392-y |
Similar Items
-
In silico prediction of novel therapeutic targets using gene–disease association data
by: Enrico Ferrero, et al.
Published: (2017-08-01) -
Advances in the molecular understanding of G protein-coupled receptors and their future therapeutic opportunities
by: Daniel N. Obot, et al.
Published: (2021-09-01) -
Insights into vector control through the modulation of An. gambiae G protein-coupled receptors
by: Regna, Kimberly
Published: (2015) -
Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation and function.
by: Ivone eGomes, et al.
Published: (2014-12-01) -
Biological Redundancy of Endogenous GPCR Ligands in the Gut and the Potential for Endogenous Functional Selectivity
by: Georgina eThompson, et al.
Published: (2014-11-01)